跳至主要内容
临床试验/CTRI/2025/12/098725
CTRI/2025/12/098725尚未招募不适用

UTILITY OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE SELECTED USING KENT REPERTORY IN MANAGING PATIENTS OF IRRITABLE BOWEL SYNDROME HAVING OCCUPATIONAL STRESS

Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

Irritable Bowel Syndrome IBS is a chronic functional gastrointestinal disorder affecting about 4.1 percent of the global population and 4.2 to 7.5 percent of people in India. It causes abdominal pain, disturbed bowel habits, reduced quality of life, and lower work productivity. Research shows a strong link between IBS and psychological factors such as stress, anxiety, and occupational pressure.

Homeopathy has shown promising results in managing chronic functional disorders like IBS, especially when the treatment is individualized. Previous studies have reported significant improvement when remedies are selected based on the totality of symptoms. However, very few studies have used Kents Repertory in a structured way, particularly for patients with stress related or occupation related IBS.

This study aims to evaluate the usefulness of individualized homoeopathic medicines selected through Kent repertory in patients suffering from IBS with occupational stress. It also aims to study the relationship between IBS severity and work stress levels and to compare IBS SSS and Work Stress Scale scores before and after treatment. Patients will be assessed every 15 days over a period of four months to observe progressive changes.

The study hopes to provide evidence for an integrated homeopathic approach in psychosomatic conditions by combining repertorial analysis, individualized prescribing, and stress assessment.

研究设计

研究类型
Interventional

入排标准

年龄范围
22.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 22-50 years, Having occupational stress of mild range assessed through WSS ( workplace stress scale ).
  • Patients diagnosed with irritable bowel syndrome (IBS) as per Rome IV criteria.
  • Patients who give written informed consent.

排除标准

  • Patients with organic gastrointestinal diseases (e.g., inflammatory bowel disease, celiac disease, malignancy).
  • Patients with uncontrolled systemic illnesses (e.g., diabetes, hypertension, renal/liver failure).
  • Patients currently on other long-term treatment for IBS.
  • Pregnant and lactating women.

研究者

发起方
Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr VANDANA NARESH KHEMANI

Jawaharlal Nehru Homoeoopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验